BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 4362523)

  • 1. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL; Rios A
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of methanol extraction residue and therapeutic irradiation against established isografts and simulated local recurrence of mammary carcinomas.
    Yron I; Cohen D; Robinson E; Haber M; Weiss DW
    Cancer Res; 1975 Jul; 35(7):1779-90. PubMed ID: 1093676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoimmunotherapy of syngeneic mouse mammary carcinomas employing methanol extraction residue.
    Cohen D; Yron I; Grover NB; Weiss DW
    Ann N Y Acad Sci; 1976; 277(00):195-208. PubMed ID: 793479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
    Milas L; Hunter N; Withers HR
    Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 8. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
    Zbar B; Canti G; Rapp HJ; Ashley MP; Sukumar S; Bast RC
    Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
    [No Abstract]   [Full Text] [Related]  

  • 14. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T; Tokunaga T; Murohashi T
    J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract]   [Full Text] [Related]  

  • 17. Methanol extraction residue of BCG in the treatment of transplanted rat tumours.
    Hopper DG; Pimm MV; Baldwin RW
    Br J Cancer; 1975 Feb; 31(2):176-81. PubMed ID: 169861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Fisher B; Taylor S; Levine M; Saffer E; Fisher ER
    Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukemoid reaction in BALB-c mice bearing transplanted tumors.
    Kodama T; Sendo F; Kobayashi H
    Cancer Res; 1974 Jan; 34(1):176-80. PubMed ID: 4809456
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
    Liotta LA; Kleinerman J; Saidel GM
    Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.